Vasopressor and Inotropic Therapy Flashcards
Vasopressors
Drugs that cause vasoconstriction
Inotropes
Change the strength of contraction
Chronotropes
Change the rate of contraction
Indications for therapy
Decrease in SBP of >30 mmHg from baseline with clinical signs/symptomatology
Decrease in MAP >60 from baseline
Poor organ perfusion secondary to changes in BP or CO (brain, heart, kidney, etc)
Decreased myocardial contraction
Location of alpha-1/alpha 2 adrenergic receptors
Vascular wall
Heart
Effect of alpha-1/alpha 2 adrenergic receptors
Vascular wall-vasoconstriction
Heart- Increased duration of contraction without increased chronotropy
Location of beta adrenergic receptors
Beta-1: heart
Beta-2: blood vessels, lungs
Effects of beta adrenergic receptors
Heart: increased inotropy and chronotropy
Blood vessels and lungs: vasodilation
Location of dopamine receptors
Renal
Splanchnic
Coronary
Cerebral
Effects of dopamine receptors
Vasodilation
Generic name of Neosynephrine
Phenylephrine
Generic name of Levophed
Norepinephrine
Generic name of Adrenalin
Epinephrine
Generic name of Inotropin
Dopamine
Receptors phenylephrine affects
Alpha-1 (very strong effect)
Predominant clinical effects of phenylephrine
Increased SVR
Increased CO
Receptors norepinephrine affects
Alpha-1 (very
strong effect)
Beta-1 (moderate effect)
Predominant clinical effects of norepinephrine
Increased SVR
Increased CO
Receptors epinephrine affects
Alpha-1 (very strong effect)
Beta-1 (very strong effect)
Beta-2 (moderate effect)
Predominant clinical effects of epinephrine
Increased CO Decreased SVR (low dose) Increased SVR (high dose)
Receptors 0.5 to 2 mcg/kg/min of dopamine affect
Beta-1 (weak effect)
Dopaminergic (moderate effect)
Predominant clinical effects of 0.5 to 2 mcg/kg/min of dopamine
CO
Receptors 5-10 mcg/kg/min of dopamine affect
Alpha-1 (weak effect)
Beta-1 (moderate effect)
Dopaminergic (moderate effect)
Predominant clinical effects of 5-10 mcg/kg/min of dopamine
Increased CO
Increased SVR
Receptors 10-20 mcg/kg/min of dopamine affect
Alpha-1 (moderate effect)
Beta-1 (moderate effect)
Dopaminergic (moderate effect)
Predominant clinical effects of 10-20 mcg/kg/min of dopamine
Increased SVR
Receptors dobutamine affects
Not much alpha-1 effect
Beta-1 (very strong effect)
Beta-2 (moderate effect)
Predominant clinical effects of dobutamine
Increased CO
Decreased SVR
Dobutamine is solely in vasculature
Good inotrope and chronotrope
Receptors isoproterenol affects
Beta-1 (very strong effect)
Beta-2 (very strong effect)
Predominant clinical effects of isoproterenol
Increased CO
Decreased SVR
What is the indication for norepinephrine (Levophed)?
Most potent vasoconstrictor
Half life is minutes, so keep on it!
Used in septic shock with decreased EF or decreased CO along with decreased SVR
Neg inotrope
Adverse effects of norepinephrine
Toxicity: Peripheral ischemia Tachycardia Dysrhythmias: Ectopy Tachyrhythmias Extravasation Phentolamine- alpha blocker to help minimize this- inject topically
Use of phenylephrine (Neosynephrine)
1/2 life is minutes
Optimal in spinal shock ideal in medication or procedure-induced hypotension
Use of dobutamine
1/2 life is mins
Used with decreased EF or decreased CO
Septic shock with decreased CO/EF, myocardial stun post surgery, or MI
Trauma
Adverse effects of phenylephrine
Toxicity:
Renal vascular necrosis
Peripheral ischemia
Dysrhythmias- ectopy
Adverse effects of dobutamine
Toxicity- hypotension
Dysrhythmias- ectopy, tachyrhythmias
Use of dopamine
Borderline BP and HR
1/2 life is mins
Used in septic shock with decreased EF or decreased CO along with decreased SVR
Adverse effects of dopamine
Toxicity: Peripheral ischemia Tachycardia Dysrhythmias: Ectopy Tachyrhythmias
Uses for epinephrine
Used in fulminant cardiac arrest, anaphylaxis, septic shock, v-fib, v-tach without a pulse, asystole, EMD
Adverse effects of epinephrine
Toxicity: Peripheral ischemia Tachycardia Dysrhythmias: Ectopy Tachyrhthmias
Doses of epinephrine
For anaphylaxis: 1:1000 = 1 mg/mL injectable 0.3 mg SC or IM For cardiac arrest 1:10,000= 1 mg/10 mL
Uses for isoproterenol
Tx for bradycardia in pts with heart transplant
Side effects of isoproterenol
Tachycardia
Hypotension
MOA of vasopressin
Increases intracellular calcium, maintaining vascular tone in vascular smooth muscle
Uses for vasopressin
Used in fulminant cardiac arrest, sepsis, septic shock
Under what condition should any of these agents be used?
Pressor therapy should ONLY be utilized when fluid status is optimized